Drugmaker AstraZeneca recently exempted Louisiana providers from its 340B contract pharmacy limits, while GSK reduced the number of pharmacies authorized [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.